|
a randomized, open-label phase 3 study of amivantamab and mfolfox6 or folfiri versus cetuximab and folfox6 or folfiri as first-line treatment in participants with kras/nras and braf wild-type unresectable or metastatic left-sided colorectal cancer
|
26-09-202425-11-2028
|
Penyelidik Bersama
|
|
a randomized, double-blind study to compare the pharmacokinetics between abp 234 and keytruda® (pembrolizumab) in subjects with early-stage non-squamous non-small cell lung cancer as adjuvant treatment following resection and platinum-based chemotherapy
|
25-07-202424-05-2028
|
Ketua Projek
|
|
an open-label, multi-center, single arm, rollover study of gme751 (proposed pembrolizumab biosimilar) in
participants who are eligible for continued pembrolizumab treatment after participation in cgme751a12101 or
cgme751a12301 studies
|
20-11-202419-05-2028
|
Penyelidik Bersama
|
|
a phase iii, open-label, sponsor-blind, randomized study of dato-dxd with or without osimertinib versus platinum-based doublet chemotherapy for participants with egfr-mutated locally advanced or metastatic non-small cell lung cancer whose disease has...
|
26-09-202425-03-2028
|
Penyelidik Bersama
|
|
a phase 1b/2, open-label, randomized study of vudalimab in combination with chemotherapy or pembrolizumab in combination with chemotherapy as first-line treatment in patients with advanced non-small cell lung cancer
|
13-05-202412-08-2027
|
Ketua Projek
|
|
a randomized, double-blind, parallel-group study to compare efficacy, safety, and immunogenicity of gme751 (proposed pembrolizumab biosimilar) and eu-authorized keytruda® in adult participants with untreated metastatic non-squamous non-small cell lung can
|
21-12-202320-06-2027
|
Penyelidik Bersama
|
|
randomized, multicenter, multinational, double-blind study to compare the pharmacokinetics, efficacy, safety and immunogenicity of mb12 (proposed pembrolizumab biosimilar) versus keytruda® in combination with chemotherapy for the treatment of patients
|
17-04-202516-05-2027
|
Ketua Projek
|
|
an fmri study of default mode network between head and neck cancer patients with different alterations in quality of life after radiotherapy
|
22-02-202421-02-2027
|
Penyelidik Bersama
|
|
phase 1 study investigating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of the anti‑ox40 agonist monoclonal antibody bgb-a445 in combination with the anti-pd-1 monoclonal antibody tislelizumab in patients with advanced s
|
10-11-202209-11-2025
|
Penyelidik Bersama
|
|
a randomized, double-blind study evaluating the efficacy, safety, and immunogenicity of abp 206 compared with opdivo® (nivolumab) in subjects with treatment-naïve unresectable or metastatic melanoma
|
04-01-202403-10-2025
|
Penyelidik Bersama
|
|
delineating the immunogenic roles of folfox-induced extracellular vesicles via the toll-like receptor 4 (tlr4) pathway in colorectal cancer
|
01-09-202231-08-2025
|
Penyelidik Bersama
|
|
a randomized, double-blind study evaluating pharmacokinetic similarity of abp 206 compared with opdivo® (nivolumab) in resected stage iii or stage iv melanoma subjects in the adjuvant setting
|
22-06-202321-08-2025
|
Penyelidik Bersama
|
|
a randomized, open-label, phase 3 study of cosibelimab (ck-301) in combination with platinum+pemetrexed chemotherapy in subjects with first-line metastatic non-squamous non-small cell lung cancer [protocol no. ck-301-301]
|
10-06-202109-06-2025
|
Penyelidik Bersama
|
|
sox9 and nanog expression as a predictive marker for chemotherapy response in triple-negative breast cancer
|
11-11-202110-11-2024
|
Penyelidik Bersama
|
|
immuno-capture of circulating galectin 9-bound extracellular vesicles using superparamagnetic beads via conventional flow cytometry
|
16-01-202315-07-2024
|
Penyelidik Bersama
|
|
design, efficacy evaluation and clinical validation of a circanapc7 basescope probe for the detection of folfox chemoresistant colorectal cancer via in situ hybridization
|
01-07-202230-06-2024
|
Penyelidik Bersama
|
|
experiences of lung cancer patients in malaysia
|
16-03-202315-03-2024
|
Ketua Projek
|
|
end-of-life communication: a malaysian survey among oncology doctors
|
27-01-202226-05-2023
|
Ketua Projek
|
|
creation of a breast cancer database for hospital canselor tuanku muhriz
|
26-08-202125-04-2023
|
Penyelidik Bersama
|